Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Drug Metabolites in Safety Testing
HTML
Details
Locations
Year:
2002
Type:
article
Source:
Toxicology and Applied Pharmacology
DOI:
10.1006/taap.2002.9440
Authors:
T Baillie,
Mitchell N Cayen,
Hassan Fouda,
Ronald J Gerson,
James D Green,
Scott J Grossman,
Lewis J Klunk,
Bernard LeBlanc,
Darcy G Perkins,
Lisa A Shipley
show all 10
Institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
Pfizer (United States),
Bristol-Myers Squibb (United States),
Biogen (United States),
Eli Lilly (United States)
Language:
English
Topic:
Pharmacogenetics and Drug Metabolism
Subfield:
Pharmacology
Field:
Pharmacology, Toxicology and Pharmaceutics
Domain:
Life Sciences
SDG:
Good health and well-being
Open Access status:
closed
Funder:
U.S. Food and Drug Administration
OpenAlex ID:
W1992094155
FWCI:
6.8
Cites:
18
Cited by:
371
Related to:
10